Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Dehydroepiandrosterone (DHEA) sulfotransferase, known as SULT2A1, converts the androgen precursor DHEA to its inactive sulfate ester, DHEAS [corrected], thereby preventing the conversion of DHEA to an active androgen. SULT2A1 requires 3'-phosphoadenosine-5'-phosphosulfate (PAPS) for catalytic activity. We have identified compound heterozygous mutations in the gene encoding human PAPS synthase 2 (PAPSS2) in a girl with premature pubarche, hyperandrogenic anovulation, very low DHEAS levels, and increased androgen levels. In vitro coincubation of human SULT2A1 and wild-type or mutant PAPSS2 proteins confirmed the inactivating nature of the mutations. These observations indicate that PAPSS2 deficiency is a monogenic adrenocortical cause of androgen excess.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PAPSS2 is probably also important for cartilage and bone formation because this patient had short stature and abnormal bone development.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [609]
In the citing paper
“Mutations of PAPS synthase type 2 (PAPSS2) lead to impaired PAPS synthesis and thus impaired sulfation, which results in enhanced conversion of DHEA to active androgens.”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Noordam et al., 2009
In the citing paper
“Clinically this results in androgen excess manifesting with premature pubarche and a phenotype in women resembling polycystic ovary syndrome (PCOS), also observed in heterozygous carriers of major loss-of-function mutations (Noordam et al., 2009, Oostdijk et al., 2015).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Noordam et al., 2009
In the citing paper
“Low serum DHEAS is a common finding in patients with PAPSS2 deficiency (85–88).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [85]
In the citing paper
“PAPSS2 deficiency is a rare monogenic form of androgen excess caused by impaired DHEA sulfation, resulting in an increased downstream activation of unconjugated DHEA to androgens (85).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [85]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
(2016) · Dietetic and Nutrition Case Studies · doi:10.1002/9781119163411.ch73 · Cited by 1,013
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Self-citationObesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Sulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque-Ramírez, M., & San Millán, J. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 422
Premature Adrenarche—Normal Variant or Forerunner of Adult Disease?*
Ibáñez, L., DiMartino-Nardi, J., Potau, N., & Saenger, P. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0416 · Cited by 416
Research works printed but not linked: 2
- 2004, Fertil Steril, 81, 19
- 10.1210/jc.83.6.1928 · doi:10.1210/jc.83.6.1928 · Paper page
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Premature Adrenarche - A Common Condition with Variable Presentation
Utriainen, P., Laakso, S., Liimatta, J., Jääskeläinen, J., & Voutilainen, R. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369458 · Cited by 473
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419
“…in PAPSS2 can cause varying forms of bone malformation in humans, ranging from subclinical brachyolmia with only mild radiological spinal changes (237), via overt brachyolmia with dysplasia confined to the spine (15 reported cases so far) or with additional minimal epimetaphyseal changes only…”
BackgroundSelf-citationO'Reilly, M. W., Taylor, A. E., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 283
“Impaired DHEA sulfation due to 3 -phosphoadenosine 5 -phosphosulfate synthase-2 deficiency has been shown to result in a PCOS phenotype (46).”
BackgroundSelf-citation11-Oxygenated androgens in health and disease
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“Clinically this results in androgen excess manifesting with premature pubarche and a phenotype in women resembling polycystic ovary syndrome (PCOS), also observed in heterozygous carriers of major loss-of-function mutations (Noordam et al., 2009; Oostdijk et al., 2015).”
Self-citationO’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215
“Conversely, monogenic causes of androgen excess are associated with adverse metabolic consequences and can present with a PCOS phenotype (17-19).”
Self-citationAdrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
“7 Sulfotransferase SULT2A1 conjugates DHEA to DHEAS, a steroid with an important role in the regulation of adrenal androgen synthesis.(8) The adrenal synthesizes small”
BackgroundNormal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 187
“Apparent DHEA sulfotransferase deficiency is due to autosomal recessive, inactivating mutations in the gene encoding the sulfate donor to sulfotransferases (PAPSS2), causing defective DHEA sulfation (22,35).”
BackgroundInfluentialPremature adrenarche: novel lessons from early onset androgen excess
Idkowiak, J., Lavery, G. G., Dhir, V., Barrett, T. G., Stewart, P. M., Krone, N., & Arlt, W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0223 · Cited by 158
Self-citationMECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. W. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0124 · Cited by 151
Self-citationA new dawn for androgens: novel lessons from 11-oxygenated C19 steroids
Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142
“Recent work has shown that patients with impaired DHEA sulfation due to inactivating mutations in the sulfate donor-generating enzyme PAPSS2 show not only significant androgen excess, resulting from enhanced conversion of DHEA to active androgens, but also an overt PCOS phenotype (Noordam et al., 2009; Oostdijk et al.…”
Self-citationFunction and organization of the human cytosolic sulfotransferase (SULT) family
Coughtrie, M. W. H. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.005 · Cited by 142
Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Self-citationPremature adrenarche: Etiology, clinical findings, and consequences
Voutilainen, R., & Jääskeläinen, J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.06.004 · Cited by 154
Sulfation pathways from red to green
Günal, S., Hardman-Kavanaugh, R. E., Kopřiva, S., & Mueller, J. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007422 · Cited by 129
“The two mothers with WT/R329X and WT/W462Cfs*3 reported clinical features consistent with a phenotype of polycystic ovary syndrome, specifically chronic anovulation requiring ovulation induction (159).”
BackgroundInfluentialAdrenal Androgens and Androgen Precursors-Definition, Synthesis, Regulation and Physiologic Actions
Turcu, A., Smith, J. M., Auchus, R., & Rainey, W. E. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140006 · Cited by 113
“Deficiency of PAPSS2 prevents DHEA sulfation, as described in a girl who presented with premature pubarche and advanced bone age, followed by acne, hirsutism, and secondary amen-orrhea in adolescence (119).”
InfluentialZhang, Y., Zou, X., Qian, W., Weng, X., Zhang, L., Zhang, L., Wang, S., Cao, X. D., Ma, L., Wei, G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0147-y · Cited by 125
Mizumoto, S., Ikegawa, S., & Sugahara, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.437038 · Cited by 106
Idkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Self-citationThe steroid metabolome of adrenarche
Rege, J., & Rainey, W. E. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0183 · Cited by 97
“Noordam et al. (2009) examined an 8-year-old girl with early pubic and axillary hair, and concluded that the cause of hyperandrogenism in this subject was a set of compound heterozygous mutations in PAPSS2.”
Current Concepts in Disorders of Sexual Development
Öçal, G. (2011) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v3i3.22 · Cited by 88
“If this pathway is blocked, more DHEA will be converted to androstenedione and hyperandrogenism may occur (44).”
BackgroundOostdijk, W., Idkowiak, J., Mueller, J. W., House, P. J., Taylor, A. E., O'Reilly, M. W., Hughes, B. A., de Vries, M. C., Kant, S. G., Santen, G. W. E., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3556 · Cited by 81
“Three recent publications (8–10) have added 24 additional individuals, yielding a total of 43 patients with clinical and radiological phenotype description, whereas functional in vitro analysis of mutant protein activity was only provided by this study and our previous study (4).”
InfluentialSelf-citationMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Self-citationFlück, C. E. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0128 · Cited by 75
Approach to the Girl with Early Onset of Pubic Hair
Oberfield, S. E., Sopher, A. B., & Gerken, A. T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0225 · Cited by 73
“Sulfation limits the pool of DHEA available for conversion to more potent androgens, and defects in sulfation have been associated with PA (45).”
BackgroundInfluentialDawson, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.03.004 · Cited by 82
Paganini, C., Costantini, R., Superti‐Furga, A., & Rossi, A. (2019) · FEBS Journal · doi:10.1111/febs.14984 · Cited by 77
Androgen replacement therapy in Turner syndrome: a pilot study
Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0514 · Cited by 69
“Indeed, testosterone exerts its effect on adrenal androgens by mediating dehydroepiandrosterone sulfotransferase (SULT2A1) (32), recently reported to be a major regulator of androgen effects in humans (33).”
BackgroundIntestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis
Xu, P., Xi, Y., Zhu, J., Zhang, M., Luka, Z., Stolz, D. B., Cai, X., Xie, Y., Xu, M., Ren, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.048 · Cited by 76
Puberty and its disorders in the female
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00024-x · Cited by 74
Galuska, C. E., Hartmann, M. F., Sánchez-Guijo, A., Bakhaus, K., Geyer, J., Schuler, G., Zimmer, K.-P., & Wudy, S. A. (2013) · The Analyst · doi:10.1039/c3an36817c · Cited by 64
46,XX DSD: the masculinised female
Auchus, R. J., & Chang, A. Y. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.001 · Cited by 66
Adrenal cortex development and related disorders leading to adrenal insufficiency
Pignatti, E., & Flück, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111206 · Cited by 71
Li, C., Wu, Y., Chen, B., Cai, Y., Guo, J., Leonard, A. S., Kalds, P., Zhou, S., Zhang, J., Zhou, P., et al. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac253 · Cited by 70
“Mutations in PAPSS2 were reported to be associated with androgen excess (Noordam et al. 2009) and skeletal abnormalities in humans (Miyake et al. 2012; Perez-Garcia et al. 2022).”
BackgroundBiosynthesis of glycosaminoglycans: associated disorders and biochemical tests
Sasarman, F., Maftei, C., Campeau, P. M., Brunel‐Guitton, C., Mitchell, G. A., & Allard, P. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9903-z · Cited by 71
Kleiber, M. L., Laufer, B. I., Wright, E., Chater‐Diehl, E., & Singh, S. M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.016 · Cited by 63
Mueller, J. W., & Shafqat, N. (2013) · FEBS Journal · doi:10.1111/febs.12252 · Cited by 58
SULFATION PATHWAYS: Insights into steroid sulfation and desulfation pathways
Foster, P., & Mueller, J. W. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0086 · Cited by 67
Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis
Mizumoto, S., & Yamada, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.717535 · Cited by 61
“…heterozygous mutations in PAPSS2 cause hyperandrogenism, premature pubarche, and hyperandrogenic anovulation, in addition to a short stature and skeletal dysplasia, which may result from a low level of serum dehydroepiandrosterone sulfate with increasing androgen (Table 5; Noordam et al., 2009).”
BackgroundPAPSS2 mutations cause autosomal recessive brachyolmia
Miyake, N., Elcioglu, N. H., Iida, A., Isguven, P., Dai, J., Murakami, N., Takamura, K., Cho, T.-J., Kim, O.-H., Hasegawa, T., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101039 · Cited by 58
Physiology and Disorders of Puberty
Styne, D. M., & Grumbach, M. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00025-3 · Cited by 65
Human genetic disorders and knockout mice deficient in glycosaminoglycan
Mizumoto, S., Yamada, S., & Sugahara, K. (2014) · BioMed Research International · doi:10.1155/2014/495764 · Cited by 54
“The inactivation of PAPSS2 inhibits of not only the formation of PAPS but also the conversion of DHEA into DHEA-sulfate, which leads to the accumulation of DHEA in patients [45].”
BackgroundGenetics and pathophysiology of mammalian sulfate biology
Langford, R., Hurrion, E. M., & Dawson, P. A. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.08.001 · Cited by 59
A steroidogenic pathway for sulfonated steroids: The metabolism of pregnenolone sulfate
Neunzig, J., Sánchez‐Guijo, A., Mosa, A., Hartmann, M. F., Geyer, J., Wudy, S. A., & Bernhardt, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.005 · Cited by 52
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
The Physiology and Biochemistry of Adrenarche
Auchus, R. J. (2010) · Endocrine development · doi:10.1159/000321209 · Cited by 55
Clinical and Biochemical Consequences of P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2011) · Endocrine Development · doi:10.1159/000321221 · Cited by 52
van den Boom, J., Heider, D., Martin, S. R., Pastore, A., & Mueller, J. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325498 · Cited by 51
“PAPS synthases have also been implicated in steroidmetabolism (12) and hepatitis B infection (13).”
BackgroundSánchez‐Guijo, A., Neunzig, J., Gerber, A., Oji, V., Hartmann, M. F., Schuppe, H.-C., Traupe, H., Bernhardt, R., & Wudy, S. A. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.019 · Cited by 49
Steroid biomarkers in human adrenal disease
Rege, J., Turcu, A. F., Else, T., Auchus, R. J., & Rainey, W. E. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.018 · Cited by 52
“Noordam C, Dhir V, McNelis JC, Schlereth F, Hanley NA, Krone N, Smeitink JA, Smeets R, Sweep FC, Claahsen-van der Grinten HL, Arlt W, Inactivating PAPSS2 mutations in a patient with premature pubarche, N Engl J Med, 360 (2009) 2310–2318.”
BackgroundInfluentialCirculating steroid hormone variations throughout different stages of prostate cancer
Snaterse, G., Visser, J. A., Arlt, W., & Hofland, J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0155 · Cited by 49
Self-citationHuman PAPS Synthase Isoforms Are Dynamically Regulated Enzymes with Access to Nucleus and Cytoplasm
Schröder, E., Gebel, L., Eremeev, A. A., Morgner, J., Grum, D., Knauer, S. K., Bayer, P., & Mueller, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029559 · Cited by 42
“[13] referred at this point to the different cellular localisation of the two proteins.”
BackgroundAdrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Steroid sulfatase deficiency and androgen activation before and after puberty
Idkowiak, J., Taylor, A. E., Subtil, S., O'Neil, D. M., Vijzelaar, R., Dias, R. P., Amin, R., Barrett, T. G., Shackleton, C. H. L., Kirk, J. M. W., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4101 · Cited by 42
“This suggests that the sulfotransferase reaction inactivating DHEA to DHEAS is the predominant switch regulating the balance between DHEA activation and inactivation, with significant clinical implications (1, 2).”
BackgroundSelf-citationUpdate on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Placental, Renal, and Ileal Sulfate Transporter Gene Expression in Mouse Gestation1
Dawson, P. A., Rakoczy, J., & Simmons, D. G. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.098749 · Cited by 40
“In humans, impaired sulfonation has been reported in developmental dwarfism [9], skeletal dysplasias [10, 11], premature pubarche [12], and reduced acetaminophen metabolism [13].”
BackgroundWitchel, S. F., & Topaloglu, A. K. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00017-2 · Cited by 35
Adrenal androgens, adrenarche, and zona reticularis: A human affair?
Dumontet, T., & Martinez, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111239 · Cited by 44
Damgaard–Olesen, A., Johannsen, T. H., Holmboe, S. A., Søeborg, T., Petersen, J. H., Andersson, A., Aadahl, M., Linneberg, A., & Juul, A. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.12.042 · Cited by 39
Mueller, J. W., Idkowiak, J., Gesteira, T. F., Vallet, C., Hardman-Kavanaugh, R. E., van den Boom, J., Dhir, V., Knauer, S. K., Rosta, E., & Arlt, W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002248 · Cited by 39
“Inactivating PAPSS2 mutations have been reported to present with skeletal malformations, specifically variable phenotypes of spondyloepimetaphyseal dysplasia (14, 15), and with biochemical and clinical evidence of androgen excess (13, 14).”
InfluentialSelf-citationSkeletal Dysplasias Caused by Sulfation Defects
Paganini, C., Tota, C. G., Superti‐Furga, A., & Rossi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082710 · Cited by 44
Steroids - From Physiology to Clinical Medicine
Ostojić, S. M. (2012) · InTech eBooks · doi:10.5772/46119 · Cited by 41
Iida, A., Simsek-Kiper, P. Ö., Mizumoto, S., Hoshino, T., Elcioglu, N., Horemuzova, E., Geiberger, S., Yesil, G., Kayserili, H., Utine, G. E., et al. (2013) · Human Mutation · doi:10.1002/humu.22377 · Cited by 37
“Therefore, the association of PAPSS2 mutation with abnormal androgen metabolism previously reported in a patient with spondylodysplasia and premature pubarche [Noordam et al., 2009] is not fortuitous.”
BackgroundMethodResultInfluentialBaş, S., Güran, T., Atay, Z., Haliloğlu, B., Abalı, S., Turan, S., & Bereket, A. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369395 · Cited by 36
Plasma and Urinary Sulfate Determination in a Cohort with Autism
Bowling, F. G., Heussler, H., McWhinney, A., & Dawson, P. A. (2012) · Biochemical Genetics · doi:10.1007/s10528-012-9550-0 · Cited by 35
Role of sulphate in development
Dawson, P. A. (2013) · Reproduction · doi:10.1530/rep-13-0056 · Cited by 38
Styne, D. M., & Grumbach, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00025-0 · Cited by 42
Grum, D. S., van den Boom, J., Neumann, D., Matena, A., Link, N. M., & Mueller, J. W. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.039 · Cited by 33
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Jee, Y. H., Jumani, S., & Verónica Mericq, G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad202 · Cited by 35
Rege, J., Nanba, A. T., Auchus, R. J., Ren, J., Peng, H.-M., Rainey, W. E., & Turcu, A. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01525 · Cited by 30
Diagnosis of Diseases of Steroid Hormone Production, Metabolism and Action
Honour, J. W. (2009) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v1i5.209 · Cited by 32
“One recent report of premature pubarche described a child with hyperandrogenic anovulation, who had low plasma DHAS due to defect of the sulphotransferase SULT2A1 through a defect in sulphate delivery from PAPS through inactivating mutations in PAPSS2 (129).”
BackgroundUpdate on adrenal steroid hormone biosynthesis and clinical implications
Bacila, I. A., Elder, C. J., & Krone, N. P. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-313873 · Cited by 39
Self-citationGenomic Deletion at 10q23 in Prostate Cancer: More Than PTEN Loss?
Poluri, R. T. K., & Audet‐Walsh, É. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00246 · Cited by 27
“The few patients identified with mutations in this gene are female, and heterozygous inactivation of PAPSS2 has been associated with polycystic ovary syndrome, premature puberty, hyperandrogenic anovulation, very low DHEA-S levels, and increased androgen levels (43).”
BackgroundLouwers, Y. V., de Jong, F. H., van Herwaarden, N. A. A., Stolk, L., Fauser, B. C. J. M., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1976 · Cited by 26
Spondyloepimetaphyseal dysplasia Pakistani type: Expansion of the phenotype
Tüysüz, B., Yılmaz, S., Gül, E., Kolb, L., Bilguvar, K., Evliyaoğlu, O., & Günel, M. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35906 · Cited by 25
“Indeed, an in vitro DHEAS generation assay showed complete loss of activity of the R329X variant of PAPSS2 [Noordam et al., 2009].”
BackgroundResultInfluentialSociety for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Elhassan, Y., Hawley, J. M., Cussen, L., Abbara, A., Clarke, S. A., Kempegowda, P., Dhillon‐Smith, R. K., Thadani, P., Busby, M., Owusu‐Darkwah, L., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15265 · Cited by 31
“Mutations encoding the gene for PAPS synthase 2 (PAPSS2) are associated with impaired DHEA sulfation, resulting in a monogenic syndrome that is phenotypically similar to PCOS, featuring androgen excess and oligomenor-rhoea [8].”
Haring, R., Wallaschofski, H., Teumer, A., Kroemer, H., Taylor, A. E., Shackleton, C. H. L., Nauck, M., Völker, U., Homuth, G., & Arlt, W. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0185 · Cited by 25
“…SULT2A1 genotype showed no impact on the conversion of DHEA into DHEAS, as indicated by the lack of a significant difference between the group-specific DHEA/DHEAS ratio, previously established as a valid surrogate marker for DHEA sulfonation capacity (Arlt et al. 2006, Noordam et al. 2009).”
BackgroundSelf-citationMaiti, S., & Chen, G. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2014.992440 · Cited by 25
“This activity has been shown to be influenced due to the presence of its gene mutation and alteration in protein conformation and stability (Noordam et al., 2009; van den Boom et al., 2012).”
BackgroundPuberty in the Female and Its Disorders
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00016-6 · Cited by 35
Anorexia nervosa and adrenal hormones: a systematic review and meta-analysis
Thavaraputta, S., Ungprasert, P., Witchel, S. F., & Fazeli, P. K. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad123 · Cited by 27
MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
PUGEAT, M. M., Plotton, I., de la Perrière, A. B., Raverot, G., Déchaud, H., & Raverot, V. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0776 · Cited by 22
PAPSS2‐related brachyolmia: Clinical and radiological phenotype in 18 new cases
Bownass, L., Abbs, S. J., Armstrong, R., Baujat, G., Behzadi, G. I. N., Berentsen, R. D., Burren, C. P., Calder, A. D., Cormier‐Daire, V., Newbury-Ecob, R. A., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61282 · Cited by 19
Ibeawuchi, C., Schmidt, H., Voß, R., Titze, U., Abbas, M., Neumann, J., Eltze, E., Hoogland, A. M., Jenster, G. W., Brandt, B., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023856 · Cited by 23
“Although the alteration of PAPSS2 gene has been clinically associated to Pakistani type of spondyloepimetaphyseal dysplasia (SEMD) [34] and colon cancer [35], it has not been shown to be strongly associated to prostate cancer.”
BackgroundMethodThe Biological Roles of Steroid Sulfonation
Anthony, P. (2012) · InTech eBooks · doi:10.5772/52714 · Cited by 19
“In one case, inactivating mutations in the PAPSS2 gene were linked to premature pubarche, hyperandrogenic anovulation and increased androgen levels in a young female patient [102].”
Livadas, S., Bothou, C., Kanaka‐Gantenbein, C., Chiotis, D., Angelopoulos, N., Μacut, D., & Chrousos, G. P. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1109-2630 · Cited by 18
Yan, Y., Ubukata, M., Cody, R. B., Holy, T. E., & Gross, M. L. (2014) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-014-0901-4 · Cited by 18
Disorders of Pubertal Development
GARIBALDI, L. R., & Chemaitilly, W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00556-x · Cited by 17
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Tise, C. G., Perry, J. A., Anforth, L. E., Pavlovich, M. A., Backman, J., Ryan, K. A., Lewis, J. P., O’Connell, J. R., Yerges‐Armstrong, L. M., & Shuldiner, A. R. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.032979 · Cited by 16
“…pathologies including reduced xenobiotic clearance, skeletal dysplasia, premature pubarche, autism spectrum disorder (ASD), and neurological disease (Alberti et al. 1999; Bowling et al. 2013; Hea fi eld et al. 1990; Ahmad et al. 1998; Noordam et al. 2009; Dawson 2013; Dawson and Markovich 2005).”
Zhang, P., Zhang, L., Hou, Z., Lin, H., Gao, H. F., & Zhang, L. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.062 · Cited by 15
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Glucocorticoid Resistance in Premature Adrenarche and PCOS: From Childhood to Adulthood
Panayiotopoulos, A., Bhangoo, A., Khurana, D., Ten, S., Michl, J., & Ghanny, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa111 · Cited by 15
“During the initial investigation of PA, it is important to rule out central precocious puberty, congenital adrenal hyperplasia (CAH) [12], virilizing tumors, Cushing as well as McCune Albright syndromes, cases of activating LH receptor and exogenous hormone exposures [13], inactivating PAPS synthase type 2 mutation [1…”
BackgroundMajzoub, J. A., & Topor, L. S. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488777 · Cited by 19
Li, W., Jia, H., Li, Q., Cui, J., Li, R., Zou, Z., & Hong, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-32847-8 · Cited by 16
Brylski, O., Shrestha, P., House, P. J., Gnutt, P., Mueller, J. W., & Ebbinghaus, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.860387 · Cited by 13
“These point mutations diminish the enzyme activity and they are mainly located within the kinase domain of PAPSS2 (Kurima et al., 1998; Noordam et al., 2009; Iida et al., 2013).”
BackgroundInfluentialWang, W., Li, F., Wang, K., Cheng, B., & Guo, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043475 · Cited by 13
“spurt characteristic of in Kashin-beck disease, compromised final height, and the increased ratio of sitting height to standing height are indicative of bone dysplasia [14,16].”
BackgroundInactivating PAPSS2 Mutations in a Patient with Premature Pubarche
Eugster, E. A. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79411-9 · Cited by 13
Metadata
- Authors
- Noordam, C., Dhir, V., McNelis, J. C., Schlereth, F., Hanley, N. A., Krone, N., Smeitink, J. A., Smeets, R., Sweep, F. C. G. J., Grinten, H. L. C.-V. D., & Arlt, W.
- Affiliations
- Radboud University Nijmegen (NL)
- University of Birmingham (GB)
- University of Manchester (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-05-28
- Volume
- 360
- Issue
- 22
- Pages
- 2310-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2100539649
- Semantic Scholar
- b65ab47d0493ef75f1cb8a350fee17d86a9c73d9
- Cited by
- 169
- References
- 29
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 8 · 2019: 12 · 2018: 13 · 2017: 10 · 2016: 14 · 2015: 15 · 2014: 12 · 2013: 9 · 2012: 14
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Wellcome Trust (GR079865M)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- PAPSS2, SULT2A1, dehydroepiandrosterone sulfate, premature pubarche, hyperandrogenism, compound heterozygosity, loss-of-function mutations
- MeSH terms
- Androgens, Androstenedione, Child, Dehydroepiandrosterone, Diagnosis, Differential, Female, Heterozygote, Humans, Multienzyme Complexes, Mutation, Polycystic Ovary Syndrome, Puberty, Precocious, RNA, Messenger, Sulfate Adenylyltransferase, Testosterone, Sulfotransferases, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.